Bio-Hykon
Latest round
- Series A
Last raised
- Jul 2018
Total raised
- Undisclosed
Investors
- 1
About Bio-Hykon
Based in Shanghai, China, and founded in 2014, Bio-Hykon operates as a medical reagent and instrument manufacturer, dedicated to the research, development, and production of in vitro diagnostic reagents and instruments. The company was recognized as a Shanghai High-Tech Enterprise and Shanghai New Venture Enterprise. It also has set up a production base as well as a subsidiary in Jiangsu., LTD. Bio-Hykon is dedicated to the research, development, and production of cancer diagnostic reagents based on circulating tumor cells (CTCs) and supporting instruments. Its main products are the Breast Cancer Circulating Tumor Cell Detection Kit and the Microfluidic Multicolor Fluorescent Cell Counter. The company also developed CTC test products for other tumors such as colorectal cancer, liver cancer, lung cancer, and glioma.
Who invested in Bio-Hykon
1 investor across 1 round
See all investors in Bio-Hykon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 24, 2018
Amount
Undisclosed
Investors
Questions about Bio-Hykon
Who invested in Bio-Hykon?
Bio-Hykon has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bio-Hykon raised?
Bio-Hykon has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bio-Hykon last raise money?
Bio-Hykon's most recent round on record is a Series A, in Jul 2018.
What does Bio-Hykon do?
Based in Shanghai, China, and founded in 2014, Bio-Hykon operates as a medical reagent and instrument manufacturer, dedicated to the research, development, and production of in vitro diagnostic reagents and instruments.
Where is Bio-Hykon headquartered?
Bio-Hykon is headquartered in Shanghai, China.
Which VCs invest in companies like Bio-Hykon?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Bio-Hykon's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Bio-Hykon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.